SCOTT R. BURELL
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
JOHN H. ABELES, M.D., SCOTT BURELL, SCOTT R BURELL, F. RIGDON CURRIE, WEI RICHARD DING, MARTIN R. FELSENTHAL, DANIEL R. FORCHE, SCOTT GOTTLIEB, M.D., RICHARD D. HOCKETT, JR., M.D., ROBERT HOFFMAN, R. JUDD JESSUP, R. JUDD JESSUP, JEREMY JONES, JEREMY M. JONES, AMIT KUMAR, MARK MCDONOUGH, MARK MCGOWAN, MARK P. MCGOWAN, ROBERT WESLIE TYSON
DIRECTOR
DAVID BEN NAIM, DAVID BEN BEN NAIM, YOSEPH BORNSTEIN, SCOTT BURELL, JUAN DIAZ- CARTELLE, JUAN DIAZ-CARTELLE, HAREL GADOT, YEHEZKEL HIMELFARB, PRATIPATTI LAXMINARAIN, PRATTIPATI LAXMINARAIN, MARTIN MADDEN, MARTIN J. MADDEN, SOLOMON MAYER, DAVID BEN NAIM, SIMON SHARON, MOSHE SHOHAM, AILEEN STOCKBURGER, RACHEL VAKNIN, YOAV WAIZER, TAL WENDEROW, DAVID WILSON
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2016-11-28
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$5,000,001 - $25,000,000
Equity
2014-06-04
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$5,000,001 - $25,000,000
Equity
2013-05-06
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
$1,000,001 - $5,000,000
Equity
2012-10-01

